UNC Pleural Fluid Registry
Research with biospecimens such as blood, tissue, or body fluids can help researchers understand how the human body works. Researchers can make new tests to find diseases, understand how treatments work, or find new ways to treat a disease. The purpose of this study is to collect biospecimens for research from patients with known or suspected lung cancer. The information learned from the biospecimens may be used in future treatments. The purpose of this protocol is to create a pleural fluid registry for use in future studies.
Arms and Interventions
|Pleural Fluid Registry
Any subject who has pleural fluid buildup from lung cancer, breast cancer, or lung infection
Primary Outcome Measures
- Creation of a pleural fluid registry [32 years]
Biological specimens and corresponding clinical data from subjects will be collected during standard of care procedures and medical record abstraction to support the creation of a pleural fluid registry.
Patients who are 18 years or older
Inpatients and outpatients
Diagnosed with pleural fluid, are referred for and undergo clinically indicated drainage who have clinical evidence of:
pulmonary infection (such as fever, leukocytosis, new or worsening infiltrate on chest x-ray, or clinical deterioration) with effusion
A subject will not be eligible for inclusion in this registry if, in the investigator's (or treating clinician's) opinion, the patient has any concurrent medical condition that may preclude their ability to undergo pleural fluid drainage safely.
Contacts and Locations
|1||UNC Lingeberger Comprehensive Cancer Center||Chapel Hill||North Carolina||United States||27599|
Sponsors and Collaborators
- UNC Lineberger Comprehensive Cancer Center
- Principal Investigator: Jason Akulian, UNC Lineberger Comprehensive Cancer Center
Study Documents (Full-Text)None provided.